e-learning
resources
Milan 2017
Tuesday, 12.09.2017
Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical Indicators of Survival in Stage IV Lung Cancer: Role of Metastases (M) Descriptor
P. Zhu (Montréal, QC, Canada)
Source:
International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Session:
Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Session type:
Thematic Poster
Number:
4270
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Zhu (Montréal, QC, Canada). Clinical Indicators of Survival in Stage IV Lung Cancer: Role of Metastases (M) Descriptor. 4270
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Numbers and Stations: Impact of Examined Lymph Node on Precise Staging and Survival of Radiologically Pure-Solid Non–Small Cell Lung Cancer
Source: Virtual Congress 2020 – Thoracic surgery: developments in diagnostics and outcomes
Year: 2020
Hang Doctor: A Smartphone App to Learn and Improve Knowledge of TNM Classification in Non-Small Cell Lung Cancer (NSCLC).
Source: International Congress 2017 – Medical education, web and internet
Year: 2017
The Effect of Lipid Profile and Obesity on the Grade of Neutropenia in Patients with Small Cell Lung Cancer Treated with Etoposide-Cisplatin as First Regimen.
Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology
Year: 2019
Short Term Multidisciplinary Pulmonary Rehabilitation Is Effective In Early Stage Non Small Cell Lung Cancer
Source: Virtual Congress 2020 – Screening and early lung cancer
Year: 2020
Clinical Features and Treatment Outcome of Carcinomatous Pericarditis due to Lung Cancer.
Source: International Congress 2018 – Lung cancer: modern therapies and beyond
Year: 2018
An Evaluation of the Functional Capacity and Physical Activity Level in Patients with Breast Cancer
Source: International Congress 2017 – Assessing functional outcomes in respiratory physiotherapy
Year: 2017
Resected Non-Small Cell Lung Cancer : A 5-year Experience
Source: Virtual Congress 2020 – Localised non-small cell lung cancer
Year: 2020
Lung Cancer vs. „Young Cancer“ – Is There a Difference?
Source: Virtual Congress 2021 – COVID-19 and management of lung cancer
Year: 2021
Prognostic and predictive value of E-cathepsin for pulmonary adenocarcinomas in the IALT (International Adjuvant Lung Cancer Trial)
Source: Annual Congress 2006 - Prognostic factors in lung cancer
Year: 2006
NRG1 Fusion-Positive Lung Cancers: Clinicopathologic Profile and Treatment Outcomes from a Global Multicenter Registry
Source: International Congress 2019 – Biology of lung cancer
Year: 2019
Association Between Pain Level and Fatigue Level with Activities of Daily Living in Lung Cancer Patients Receiving Inpatient Cancer Therapy: A Pilot Study
Source: Virtual Congress 2020 – A fresh look at the spectrum of symptoms in respiratory disease
Year: 2020
The Role Of TGF-ß in Lung Cancer Development in COPD Patients
Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Year: 2020
Increase in hospital admissions in smokers with Interstitial Lung Abnormalities in the Danish Lung Cancer Screening Trial (DLCST)
Source: International Congress 2018 – COPD and chronic respiratory disease: from misclassification to radiological findings
Year: 2018
Consequences of Lung Cancer: Mortality and Comorbidity in Danish Patients with Lung Cancer 1998-2010
Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology
Year: 2019
Characterization of Patients with KRAS-Mutated Advanced Non-Small Cell Lung Cancer
Source: International Congress 2019 – Thoracic oncology: Treatment, diagnostic options and biology
Year: 2019
A Study on Various Types of Presentations of Paediatric Tuberculosis and Response to Fixed Dose Combination (FDC).
Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis
Year: 2020
Type 2 Diabetes Acentuates the Impairment in the Lung Function and Mechanics in Elderly
Source: Virtual Congress 2020 – Advances in lung function practice
Year: 2020
Effect of the Liverpool Healthy Lung Programme on Outcomes in Lung Cancer
Source: Virtual Congress 2020 – Screening and early lung cancer
Year: 2020
Intratumoral Hyperthermic Chemotherapy Injection in Peripheral Non-Small Cell Lung Cancer; a Pilot Study.
Source: Virtual Congress 2020 – Novelties in interventional pulmonology: expanding horizons
Year: 2020
Functional Outcomes Long Term Survival and Surgical Risk After Lung Volume Reduction Surgery: A 12-year Single Center Experience.
Source: International Congress 2017 – Thoracic surgery: preoperative assessment, outcome and complications
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept